Literature DB >> 18832401

Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management.

B Thanvi1, S Treadwell, T Robinson.   

Abstract

Early neurological deterioration (END) in acute ischaemic stroke is a common event. The underlying mechanisms are heterogeneous. The clinical predictors of END include severity of the initial stroke, large vessel occlusion, diabetes mellitus, hypotension, and atrial fibrillation. Serial observations and detailed assessment by the trained staff in specialised stroke units are key to the successful management of these patients. Advances in brain and vascular imaging have provided insight into the underlying mechanisms, enabling clinicians to use preventative and therapeutic interventions specifically targeted at them, though several questions still remain unanswered. END has potentially serious consequences on the short term (morbidity and death) and long term (recovery from stroke) outcomes for the patient. Therefore, attempts to prevent and treat END should be made promptly and aggressively.

Entities:  

Mesh:

Year:  2008        PMID: 18832401     DOI: 10.1136/pgmj.2007.066118

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  37 in total

1.  EGCG ameliorates the suppression of long-term potentiation induced by ischemia at the Schaffer collateral-CA1 synapse in the rat.

Authors:  Jie Ding; Gang Fu; Yan Zhao; Zhenyong Cheng; Yang Chen; Bo Zhao; Wei He; Lian-Jun Guo
Journal:  Cell Mol Neurobiol       Date:  2011-11-11       Impact factor: 5.046

2.  Challenges enrolling patients with acute ischemic stroke into cell therapy trials.

Authors:  Farhaan S Vahidy; Susan Alderman; Sean I Savitz
Journal:  Stem Cells Dev       Date:  2012-10-15       Impact factor: 3.272

3.  Early Clinical Implications of Microalbuminuria in Patients with Acute Ischaemic Stroke.

Authors:  Anupa Thampy; Christopher C Pais
Journal:  J Clin Diagn Res       Date:  2016-09-01

4.  Clinical manifestation of cancer related stroke: retrospective case-control study.

Authors:  Jeong-Min Kim; Keun-Hwa Jung; Kee Hong Park; Soon-Tae Lee; Kon Chu; Jae-Kyu Roh
Journal:  J Neurooncol       Date:  2013-01-09       Impact factor: 4.130

5.  Change in CSF Dynamics Responsible for ICP Elevation After Ischemic Stroke in Rats: a New Mechanism for Unexplained END?

Authors:  Mohammed S Alshuhri; Lindsay Gallagher; Christopher McCabe; William M Holmes
Journal:  Transl Stroke Res       Date:  2019-08-15       Impact factor: 6.829

6.  Preexisting statin use is associated with greater reperfusion in hyperacute ischemic stroke.

Authors:  Andria L Ford; Hongyu An; Gina D'Angelo; Rosana Ponisio; Patrick Bushard; Katie D Vo; William J Powers; Weili Lin; Jin-Moo Lee
Journal:  Stroke       Date:  2011-03-31       Impact factor: 7.914

7.  Nocturnal Desaturation is Associated With Neurological Deterioration Following Ischemic Stroke: A Retrospective Observational Study.

Authors:  Tae Jung Kim; Sang-Bae Ko; Han-Gil Jeong; Chi Kyung Kim; Yerim Kim; Kiwoong Nam; Heejung Mo; Sang Joon An; H Alex Choi; Byung-Woo Yoon
Journal:  J Clin Sleep Med       Date:  2017-11-15       Impact factor: 4.062

8.  Early changes of tissue perfusion after tissue plasminogen activator in hyperacute ischemic stroke.

Authors:  Hongyu An; Andria L Ford; Katie Vo; Cihat Eldeniz; Rosana Ponisio; Hongtu Zhu; Yimei Li; Yasheng Chen; William J Powers; Jin-Moo Lee; Weili Lin
Journal:  Stroke       Date:  2010-12-09       Impact factor: 7.914

9.  Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes.

Authors:  Andre D Kumar; Amelia K Boehme; James E Siegler; Michael Gillette; Karen C Albright; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-09-30       Impact factor: 2.136

10.  Identification of modifiable and nonmodifiable risk factors for neurologic deterioration after acute ischemic stroke.

Authors:  James E Siegler; Amelia K Boehme; Andre D Kumar; Michael A Gillette; Karen C Albright; T Mark Beasley; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-12-16       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.